Short answer
NovoCure Ltd (NVCR) filed an 8-K current report with the SEC on September 9, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Director Timothy Scannell retired effective September 2, 2026 after five years of board service.
NovoCure Ltd 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Director Timothy Scannell retired effective September 2, 2026 after five years of board service
- Board seat formally vacated under the Company’s Articles of Association
- Departure unrelated to disagreements with NovoCure or management
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NovoCure Ltd 8-K filings
Get the next NVCR 8-K as it lands
Follow NVCR for push alerts, or ask the research agent what this filing means.